Title:
Bad Blood: Secrets and Lies in a Silicon Valley Startup
Condition: BRAND NEW
Format: Paperback
Overview:
Bad Blood unfolds the inside story of Theranos, the Palo Alto biotech startup that promised to redefine medical testing with a finger-prick, reliable across the board machine. John Carreyrou, the prize-winning journalist who first exposed the mystery in The Wall Street Journal, takes readers on a tense, meticulously documented journey from soaring valuations to a dramatic collapse. The book leverages hundreds of interviews, internal emails, whistleblower accounts, and court filings to peel back the glossy veneer and reveal a culture of secrecy, aggressive legal intimidation, and relentless hype. It traces how founder Elizabeth Holmes galvanized Silicon Valley with a narrative of disruption, while the science behind Theranoss claims proved unreliable. The consequences were vast: billions in investment, millions of patient tests in question, and a Silicon Valley saga that challenged the boundaries between ambition and accountability. Written with brisk pace and rigorous fact-checking, Bad Blood is both a compelling true story and a rigorous case study in corporate governance, ethics, and the risks of tech-fueled hype.
What Makes This Book Stand Out:
This is investigative reporting at its most grippingdeeply sourced, relentlessly honest, and told with the confidence that comes from years of frontline work. Carreyrou doesnt merely recount events; he assembles a mosaic of voicesfrom engineers and salespeople to investors and regulatorsdrawing a vivid portrait of a company that overpromised and underdelivered. He carefully breaks down the science in accessible terms, explaining what Theranos claimed about its blood-testing technology and why those claims didnt hold up under scrutiny. The narrative crescendos with real courtroom drama, whistleblower courage, and the ethical questions every tech startup faces: when does vision outrun verifiable science, and who bears the cost when it does? Its a cautionary, page-turning education in how credible reporting can avert a broader crisis.
Who This Book Is Perfect For:
Fans of investigative journalism, business and tech non-fiction, and true-crime narratives will find Bad Blood essential. Its ideal for readers who want a rigorous, evidence-based look at one of the defining corporate scandals of the decade, as well as students of entrepreneurship and corporate governance seeking real-world lessons in ethics, risk, and due diligence. It also makes a powerful gift for professionals in healthcare, biotech, or venture capital who crave a transparent, vividly told account of how hype can outpace truthand what it takes to uncover it. This is accessible enough for casual readers while offering depth that appeals to more analytical minds.
Key Highlights:
- Unearths the true story behind Theranoss revolutionary blood-testing claims
- Profiles Elizabeth Holmes and the dynamics of Silicon Valley hype
- Shows how relentless investigative reporting can uncover fraud
- Explains the science in clear, reader-friendly terms
- Reveals the personal and legal risks faced by journalists and insiders
- Offers a sobering look at governance, oversight, and accountability
About the Author:
John Carreyrou is a renowned investigative journalist and a longtime reporter for The Wall Street Journal. He played a pivotal role in uncovering Theranoss fraudulent practices and subsequently authored Bad Blood, a National Bestseller that chronicles the rise and fall of Elizabeth Holmes and her startup. Carreyrous work earned him the Pulitzer Prize for Investigative Reporting in 2015, recognizing his perseverance and rigor in exposing wrongdoing. His reporting is guardian-like in its insistence on evidence, balance, and clarity, making complex corporate and scientific topics accessible to a broad audience without sacrificing nuance. Readers trust him for truth-telling under pressure, and Bad Blood stands as a defining example of his meticulous approach to demanding, high-stakes journalism.
Why Youll Love This Book:
Bad Blood isnt just a compelling expos; its a masterclass in narrative nonfiction. Carreyrou weaves a tightly paced investigation with human drama, turning a complex biotech story into a high-stakes thriller grounded in verifiable facts. The book gives readers practical insights into due diligence, risk assessment, and the ethical responsibilities of founders, investors, and journalists alike. Its a rare blend of gripping storytelling and rigorous journalism that clarifies how a prominent startup could mislead so manyand why steadfast reporting matters to public health, investor trust, and innovation ecosystems. This is a book that informs, warns, and captivates in equal measure, making it a standout addition to any serious non-fiction shelf.
Please Note: The individual books included in this listing will be dispatched as per the original UK ISBN and UK edition cover image shown in the image.
